Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
synlogic
4
×
biotech
clinical trials
detroit blog main
detroit top stories
medical devices
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
deals
ginkgo bioworks
hyperammonemia
indiana blog main
indiana top stories
microbiome
national
novartis
opioids
pfizer
What
bio
roundup
admits
advantages
ago
august
bacteria
bar
big
biology
biotech
biotechs
bioworks
brings
busy
called
classes
combinator
companies
company
comprised
days
decisions
developer
devices
drug
drugs
dug
engineered
expect
fda
gamble
ginkgo
incubator
lands
legacy
life
living
market
medco’s
Language
unset
Current search:
synlogic
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D